Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction

---
identifier: "/us/fr/2016-12654"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2016-12654"
section_name: "Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction"
positive_law: false
currency: "2016-05-31"
last_updated: "2016-05-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2016-12654"
document_type: "notice"
publication_date: "2016-05-31"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "81 FR 34348"
fr_volume: 81
docket_ids:
  - "Docket No. FDA-2016-N-0001"
fr_action: "Notice; correction."
---


#  Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of Tuesday, May 10, 2016 (81 FR 28876). The document announced a public workshop entitled “Clinical Trial Design Considerations for Malaria Drug Development.” The document was  published with the incorrect title and incorrect Internet address in the *Transcripts* section. This document corrects those errors.

**FOR FURTHER INFORMATION CONTACT:**

Lori Benner and/or Jessica Barnes, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6221, Silver Spring, MD 20993-0002, 301-796-1300.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2016-10913, appearing on page 28876 in the *Federal Register* of Tuesday, May 10, 2016, the following corrections are made:

1. On page 28876, in the first column, the title is corrected to read “Clinical Trial Design Considerations for Malaria Drug Development.”

2. On page 28876, in the second column, the *Transcripts* section is corrected to read “Please be advised that as soon as a transcript is available, it will be accessible at *http://www.regulations.gov.* It may be viewed at the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm.1061, Rockville, MD. A transcript will also be available in either hard copy or on CD-ROM, after submission of a Freedom of Information request. Written requests are to be sent to Division of Freedom of Information (HFI-35), Office of Management Programs, Food and Drug Administration, 5600 Fishers Lane, Rm. 6-30, Rockville, MD 20857. Transcripts will also be available on the Internet at *http://www.fda.gov/Drugs/NewsEvents/ucm490084.htm* approximately 45 days after the workshop.

If you need special accommodations because of a disability, please contact Jessica Barnes or Lori Benner (see *Contact Person* ) at least 7 days in advance.”

Dated: May 24, 2016.

Leslie Kux,

Associate Commissioner for Policy.